anonymous
Guest
anonymous
Guest
I heard a rumor today that we are looking to buy Codman. J&J announced a restructuring at the beginning of the year, this could be part of that possibly? I could see us wanting to get back into the neurovascular market which we were really good at. Anyone else hear anything?